TZYM Insider Trading Activity and SEC Form 4 Filings
TZYM insider trading summary
No open-market insider purchases or sales of Tranzyme Inc (TZYM) have been reported on SEC Form 4 in the past 12 months.
Latest TZYM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 14, 2012 | Julian Baker | 10% Owner | Buy | $4K (1,482 @ $2.99) |
| Mar 14, 2012 | Baker Biotech Capital (GP), LLC | 10% Owner | Buy | $14K (4,592 @ $3.01) |
| Mar 14, 2012 | Felix Baker | 10% Owner | Buy | $168K (56,294 @ $2.99) |
| Mar 14, 2012 | Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Buy | $104K (34,544 @ $3.01) |
| Mar 14, 2012 | Julian Baker | 10% Owner | Buy | $22K (7,484 @ $2.99) |
| Mar 14, 2012 | Julian Baker | 10% Owner | Buy | $168K (56,294 @ $2.99) |
| Mar 14, 2012 | Baker Brothers Life Sciences Capital (GP), LLC | 10% Owner | Buy | $168K (56,294 @ $2.99) |
| Mar 14, 2012 | Baker Biotech Capital (GP), LLC | 10% Owner | Buy | $22K (7,484 @ $2.99) |
| Mar 14, 2012 | 14159 capital (GP), LLC | 10% Owner | Buy | $4K (1,482 @ $2.99) |
| Mar 14, 2012 | Julian Baker | 10% Owner | Buy | $14K (4,592 @ $3.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.